Skip to main content

Table 1 Baseline characteristics of subjects stratified by gender

From: Sex-specific contribution of lipid accumulation product and cardiometabolic index in the identification of nonalcoholic fatty liver disease among Chinese adults

Variables

Women (n = 7630)

χ2/Z

P value a

Men (n = 6777)

χ2/Z

P value a

non-NAFLD (n = 5600)

NAFLD (n = 2030)

non-NAFLD (n = 2514)

NAFLD (n = 4263)

Age (years)

41 (32,53)

55 (45,63)

− 28.372

<0.001

47 (35,60)

48 (37,57)

−2.539

0.011

Current smoking (%)

350 (6.25)

112 (6.40)

0.060

0.807

1055 (41.96)

2260 (53.01)

77.264

<0.001

Regular exercising (%)

2948 (52.64)

849 (41.82)

69.775

<0.001

1236 (49.16)

1361 (31.93)

198.831

<0.001

BMI (Kg/m2)

22.39 (20.67,24.28)

26.15 (24.29,28.35)

−44.559

<0.001

23.97 (22.19,25.74)

26.90 (25.11,29.00)

−39.727

<0.001

WC (cm)

71 (67,77)

81 (76,86)

−42.645

<0.001

80 (76,85.25)

88 (83,93)

−37.476

<0.001

WHtR

0.44 (0.42,0.48)

0.51 (0.48,0.55)

− 43.521

<0.001

0.47 (0.44,0.50)

0.51 (0.48,0.54)

−36.3

<0.001

LAP (cm.mol/L)

11.00 (6.00,19.56)

35.41 (22.46,54.73)

−48.078

<0.001

16.08 (9.00,25.76)

39.60 (24.13,63.50)

−43.466

<0.001

CMI

0.24 (0.15,0.39)

0.61 (0.39,0.95)

−44.588

<0.001

0.38 (0.25,0.60)

0.81 (0.51,1.31)

−38.499

<0.001

WBC (109/L)

5.81 (4.91,6.83)

6.34 (5.41,7.40)

−13.730

<0.001

6.10 (5.20,7.17)

6.69 (5.77,7.72)

−14.980

<0.001

SBP (mmHg)

120 (110,132)

136 (122,151)

−28.521

<0.001

128 (117,142)

134 (123,147)

−12.480

<0.001

DBP (mmHg)

71 (64,78)

77 (70,86)

−21.709

<0.001

76 (69,84)

81 (74,90)

−16.262

<0.001

TG (mmol/L)

0.83 (0.60,1.18)

1.52 (1.07,2.11)

−40.024

<0.001

1.03 (0.75,1.47)

1.73 (1.20,2.53)

−34.564

<0.001

TC (mmol/L)

4.69 (4.15,5.34)

5.21 (4.60,5.88)

−19.221

<0.001

4.61 (4.09,5.21)

4.87 (4.33,5.48)

−11.856

<0.001

HDL-C (mmol/L)

1.54 (1.33,1.78)

1.28 (1.12,1.49)

−28.916

<0.001

1.27 (1.09,1.48)

1.09 (0.94,1.26)

−25.385

<0.001

LDL-C (mmol/L)

2.80 (2.32,3.37)

3.36 (2.83,3.96)

−24.385

<0.001

2.92 (2.46,3.44)

3.18 (2.68,3.70)

−12.513

<0.001

FPG (mmol/L)

4.97 (4.71,5.26)

5.37 (5.03,5.90)

−30.224

<0.001

5.16 (4.85,5.51)

5.39 (5.03,5.97)

−17.626

<0.001

ALT (U/L)

13 (10,17)

19 (14,26)

−33.115

<0.001

17 (13,23)

25 (18,36)

−29.760

<0.001

AST (U/L)

17 (15,20)

20 (17,24)

−19.249

<0.001

19 (16,22)

21 (18,25)

−14.857

<0.001

GGT (U/L)

14 (11,18)

21 (16,29)

−35.491

<0.001

21 (16,30)

33 (24,49)

−30.714

<0.001

BUN (mmol/L)

4.50 (3.76,5.33)

4.82 (4.09,5.71)

−10.698

<0.001

5.23 (4.46,6.13)

5.21 (4.47,6.08)

− 1.083

0.279

Scr (μmol/L)

53 (48,58)

53 (48,59)

−1.531

0.126

73 (67,80)

73 (66,80)

−1.549

0.121

UA (μmol/L)

253 (221,289)

297 (258,343)

−28.558

<0.001

343 (299,390)

383 (334,438)

−20.998

<0.001

  1. Data were expressed as median (interquartile range) and numbers (percentage) as appropriate.
  2. Abbreviations: NAFLD nonalcoholic fatty liver disease, BMI body mass index, WC waist circumference, WHtR waist-to-height, LAP lipid accumulation product, CMI cardiometabolic index, WBC white blood cell count, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol, FPG fasting blood glucose, ALT alanine aminotransferase, AST aspartate aminotransferase, GGT γ-glutamyltransferase, BUN blood urea nitrogen, Scr serum creatinine, UA uric acid
  3. a. Comparisons of continuous variables between groups were tested by Mann-Whitney U test due to skewed distribution and categorical variables between groups were tested by chi-squared test
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X